Max 2026 introduces OpenPBR as the default material, enhances the Vertex Weld Modifier for splines, and boosts performance across key modifiers.

The Vertices'N'Faces structure (VNF) holds the data used by polyhedron() to construct objects: a vertex list and a list of faces. This library makes it easier to construct polyhedra by providing ...

In the latest quarter, 8 analysts provided ratings for Vertex VERX, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts ...

Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeutics before reaching the clinic. Verve, which attributed Vertex’s action to its changing R&D priorities, is ...

“Vertex’s 2024 financial results demonstrated the power of our business and financial model, which is built to deliver consistent and durable mid-to-high teens revenue growth with strong ...

The end of the Vertex-Verve collaboration comes as investors are reevaluating once sky-high expectations for the gene editing industry as commercial realities set in. Shares of Verve and top companies ...

The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies together. A trend in gene therapy setbacks continues as Vertex Pharmaceuticals ...

Data supplied by Morningstar and accurate on Sep 30, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...